IMCD stock holds after half year revenue rises 16.1 percent
Published on 08/19/2026 at 19:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
IMCD N.V. (NL0010801007) is tied to a €8.00 per share cash offer announced on July 24, 2026, while the company's half-year revenue rose 16.1 percent to €359.9 million in the six months ended June 30, 2026.
The same half-year report showed EBITDA of €58.9 million, up from €54.9 million a year earlier, and basic earnings per share of 12.5 cents versus 11.8 cents in the prior-year period.
Offer terms drive attention
The transaction values IMCD at approximately €1.2 billion and remains subject to shareholder, regulatory and High Court approvals, according to the half-year report dated August 19, 2026. The offer price implies a clear cash exit reference for investors, while the operating numbers still show a business that expanded sales and earnings in the first half.
Revenue in the six months ended June 30, 2026 was €359.9 million, compared with €309.9 million in the same period of 2025, a gain of 16.1 percent. EBITDA increased 7.3 percent to €58.9 million, even as operating profit eased to €24.0 million from €24.6 million.
Margins and cash flow
Free cash flow before strategic capital expenditure improved to €67.6 million from €50.4 million a year earlier, while net debt excluding leases increased to €176.5 million from €133.5 million at December 31, 2025. That mix matters because it shows stronger operating cash generation alongside a higher borrowing load.
Analyst views remain constructive on average, with 15 analysts in the latest overview assigning a mean target of €112.70, which sits 27.1 percent above the quoted price of €88.70. The spread between €75.00 and €137.00 also shows a wide range of views on the name.
What IMCD sells
IMCD distributes specialty chemicals and ingredients across sectors such as food, pharma, personal care and coatings, so its half-year revenue mix is driven by a broad set of end markets rather than a single product cycle. That diversified footprint helps explain why the company can post higher revenue even when margins move more gradually.
Price and setup
IMCD shares were quoted at €88.70 in Amsterdam at 3:17 p.m. local time on August 19, 2026. The stock now trades below the average analyst target and close to the announced €8.00 per share offer reference only after adjusting for the company's Dutch listing context.
More on IMCD stock
Company: IMCD N.V.
ISIN: NL0010801007
Ticker: IMCD
Exchange: Euronext Amsterdam
Sector / Industry: Materials / Specialty Chemicals
Index membership: AEX
Market cap: €6.68 billion
Next earnings date: September 2026
IMCD specialty chemicals
IMCD's specialty chemicals and ingredients portfolio covers food, nutrition, pharmaceuticals, personal care, coatings and industrial applications.
IMCD stock context
IMCD shares were quoted at €88.70 in Amsterdam at 3:17 p.m. local time on August 19, 2026.
